OCULAR THERAPEUTIX, INC·4

Feb 2, 4:36 PM ET

Goldstein Michael H. 4

4 · OCULAR THERAPEUTIX, INC · Filed Feb 2, 2018

Insider Transaction Report

Form 4
Period: 2018-01-31
Goldstein Michael H.
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-01-31+83,50083,500 total
    Exercise: $5.47Exp: 2028-01-30Common Stock (83,500 underlying)
Footnotes (1)
  • [F1]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Documents

1 file
  • 4
    a4.xmlPrimary

    4